The effect of trisomy 21 on the patterns of polypeptide synthesis in human fibroblasts.
In addition to direct gene dosage effects, the deleterious phenotypic consequences of aneuploidy may result from secondary regulatory effects on the production and degradation of gene products coded for by other chromosomes. In an initial test of the hypothesis that extensive secondary effects play an important role in the phenotypic consequences of aneuploidy, we have used two-dimensional gel electrophoresis with radioautography to look for such secondary effects among the polypeptides synthesized by human fibroblasts grown in vitro. The polypeptide patterns of fibroblast strains from four trisomy 21 subjects and one trisomy 21/normal mosaic were compared to those from five matched normal subjects. Of approximately 850 polypeptides visualized, only four show a pattern of variation which may be related to trisomy 21. Additional differences in polypeptide concentrations were found among the strains, attributable to genetic heterogeneity between donor individuals and differences in tissue of origin. These results indicate that, at least in fibroblasts in vitro, trisomy 21 does not cause major regulatory changes in the rates of production and degradation of a large number of polypeptides.
D000328:Adult; D000782:Aneuploidy; D002478:Cells, Cultured; D002675:Child, Preschool; D002874:Chromosome Mapping; D004314:Down Syndrome / Q000378:metabolism*; D005260:Female; D005333:Fetus; D005347:Fibroblasts / Q000378:metabolism; D005815:Genetic Code; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D010452:Peptide Biosynthesis; D010641:Phenotype; D014176:Protein Biosynthesis